Physician
MT Morris Medical Group PLLC
MT Morris Medical Group PLLC was paid $1.58M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 51% of everything it billed.
33Billing provider infoMT MORRIS MEDICAL GROUP PLLC
MOUNT MORRIS, MI 48458
MOUNT MORRIS, MI 48458
33aNPI1023389244assigned 01/19/2012
33bProvider typeInternal Medicine Physician
28Total paid$1.58M
24GClaims59,909
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Michigan
Rank by total paid#78 of 816
Median peer was paid$70K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,639 | $300K | |
| 2019 | 9,899 | $256K | |
| 2020 | 5,917 | $189K | |
| 2021 | 7,800 | $211K | |
| 2022 | 7,034 | $198K | |
| 2023 | 8,795 | $214K | |
| 2024incomplete | 9,825 | $210K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 51% | 10,837 | 10,214 | $804K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 8,168 | 7,604 | $435K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 7.3% | 1,220 | 1,206 | $115K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.3% | 802 | 799 | $68K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.0% | 451 | 440 | $47K |
| 90756 | 1.3% | 856 | 847 | $20K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,869 | 1,564 | $16K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 130 | 125 | $12K |
| 93000 | <1% | 1,171 | 1,154 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,398 | 1,373 | $9K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 111 | 111 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 861 | 857 | $8K |
47 more codes
| 81002 | <1% | 2,089 | $5K | |
| 99406 | <1% | 405 | $3K | |
| 96160 | <1% | 223 | $3K | |
| 96127 | <1% | 994 | $3K | |
| 99442 | <1% | 146 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 15 | $2K |
| 90661 | <1% | 54 | $2K | |
| 94010 | <1% | 60 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 14 | $1K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 171 | $918.22 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 456 | $712.84 |
| 99441 | <1% | 100 | $682.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 49 | $549.13 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 17 | $537.64 |
| 81025 | <1% | 76 | $537.31 | |
| 90715 | <1% | 12 | $374.76 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 26 | $317.53 |
| 81003 | <1% | 205 | $298.07 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 20 | $171.42 |
| 99000 | <1% | 13 | $117.71 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13 | $30.58 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 1,044 | $20.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 75 | $0.50 |
| 3074F | <1% | 2,986 | $0.26 | |
| 3078F | <1% | 2,552 | $0.23 | |
| 3079F | <1% | 1,786 | $0.18 | |
| 3008F | <1% | 2,356 | $0.14 | |
| 3075F | <1% | 843 | $0.11 | |
| 3077F | <1% | 95 | $0.03 | |
| 1159F | <1% | 825 | $0.02 | |
| 1160F | <1% | 1,213 | $0.02 | |
| 4037F | <1% | 723 | $0.02 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 2,758 | $0.00 |
| 3725F | 0% | 805 | $0.00 | |
| 3288F | 0% | 25 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 1,533 | $0.00 |
| 4035F | 0% | 52 | $0.00 | |
| 1036F | 0% | 1,606 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,315 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 320 | $0.00 |
| 3044F | 0% | 421 | $0.00 | |
| 1035F | 0% | 124 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 103 | $0.00 |
| 1126F | 0% | 1,100 | $0.00 | |
| 1034F | 0% | 1,112 | $0.00 | |
| 1125F | 0% | 1,093 | $0.00 | |
| 90694 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABDEL-HALIM, AHMAD (PARTNER)
| Provider | Location | Paid |
|---|---|---|
| Ahmad Abdel-Halim, M.D., PLLC | Flint, MI | $66K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.